An analyst rating is a buy, hold, or sell assessment indicating how professional analysts or an evaluation service view a company’s investment potential and risk. Ratings are opinions, not predictions, and may disagree or fail to anticipate market events. section 2.5 section 2.6
Common rating measures separate different sources of judgment:
- SA Analyst Rating aggregates ratings from platform users. section 2.5.1
- Wall Street Rating aggregates recommendations from professional analysts. section 2.5.1
- Quant Rating is calculated by a platform algorithm. section 2.5.1
- Rating changes can reveal shifts in market sentiment, while a single favorable score should not replace independent due diligence. section 2.5.2 section 2.6
Table 2.13 Company ratings based on the Seeking Alpha platform
|
Company
|
SA analyst rating
|
Wall Street rating
|
Quant rating
|
|---|---|---|---|
|
NVIDIA (NVDA)
|
3.83
|
4.56
|
3.38
|
|
Pfizer (PFE)
|
3.18
|
3.56
|
3.40
|
|
Aeva Technologies (AEVA)
|
2.50
|
4.40
|
4.99
|
|
Innoviz (INVZ)
|
—
|
4.25
|
3.35
|
|
Ouster (OUST)
|
3.33
|
5.00
|
4.50
|
|
Luminar Technologies (LAZR)
|
3.25
|
2.75
|
2.63
|
|
Sumitomo Mitsui Financial Group (SMR)
|
2.60
|
4.00
|
3.47
|
|
For the latest numbers, go to
https://seekingalpha.com/.
|
Compare crowdsourced, Wall Street, and quantitative ratings for companies including NVIDIA, Pfizer, and several speculative technology firms. section 2.5.1
Reading a rating trend
NVIDIA’s rating history shows strong-buy and buy recommendations alongside a gradual decline in confidence over time. The overall rating remained excellent, but the change itself supplied a reason to investigate rather than an automatic buy signal. section 2.5.1
